We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The average brokerage recommendation (ABR) for Hims & Hers Health (HIMS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The average brokerage recommendation (ABR) for NextEra (NEE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
According to the average brokerage recommendation (ABR), one should invest in Nvidia (NVDA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
While the top- and bottom-line numbers for Wix.com (WIX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The headline numbers for Globale Online (GLBE) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Helios Technologies (HLIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Qifu Technology, Inc. (QFIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Texas Pacific (TPL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
UNITY Biotechnology (UBX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Capital Southwest (CSWC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
KBC Group (KBCSY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ellington Credit (EARN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Seanergy Maritime Holdings (SHIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Dell Technologies (DELL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Interactive Brokers (IBKR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The mean of analysts' price targets for Delcath Systems (DCTH) points to a 201.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The consensus price target hints at a 27.1% upside potential for Esquire Financial (ESQ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
earnings-estimates-revisions: Archive
Is Hims & Hers Health (HIMS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Hims & Hers Health (HIMS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HIMSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in NextEra (NEE): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for NextEra (NEE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Nvidia (NVDA): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Nvidia (NVDA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NVDAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Celestica (CLS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Salesforce.com (CRM) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Compared to Estimates, Wix.com (WIX) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Wix.com (WIX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
WIXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Globale Online (GLBE) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Globale Online (GLBE) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GLBEPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Surging Earnings Estimates Signal Upside for Helios Technologies (HLIO) Stock
by Zacks Equity Research
Helios Technologies (HLIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HLIOPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Instructure (INST): Will It Gain?
by Zacks Equity Research
Instructure (INST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
INSTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Orla Mining (ORLA): Time to Buy?
by Zacks Equity Research
Orla Mining (ORLA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ORLAPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Centerra Gold (CGAU) Might be Well Poised for a Surge
by Zacks Equity Research
Centerra Gold (CGAU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CGAUPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Viant (DSP) Stock
by Zacks Equity Research
Viant (DSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DSPNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Will Archrock Inc. (AROC) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Archrock Inc. (AROC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AROCPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Qifu Technology, Inc. (QFIN) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Qifu Technology, Inc. (QFIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
QFINNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Texas Pacific (TPL) a New Strong Buy Stock
by Zacks Equity Research
Texas Pacific (TPL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
TPLPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Premier Foods (PRRFY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Premier Foods (PRRFY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PRRFYNo Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy
by Zacks Equity Research
UNITY Biotechnology (UBX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
UBXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Capital Southwest (CSWC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Capital Southwest (CSWC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CSWCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About KBC Group (KBCSY) Rating Upgrade to Strong Buy
by Zacks Equity Research
KBC Group (KBCSY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KBCSYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Ellington Credit (EARN) Rating Upgrade to Buy
by Zacks Equity Research
Ellington Credit (EARN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
EARNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Seanergy Maritime Holdings (SHIP) a New Strong Buy Stock
by Zacks Equity Research
Seanergy Maritime Holdings (SHIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SHIPPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Dell Technologies (DELL) a New Buy Stock
by Zacks Equity Research
Dell Technologies (DELL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
DELLNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Interactive Brokers (IBKR) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Interactive Brokers (IBKR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IBKRPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Delcath Systems (DCTH) points to a 201.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
DCTHPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Esquire Financial (ESQ) Could Surge 27.1%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 27.1% upside potential for Esquire Financial (ESQ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ESQNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate